Striatal interneurons in Huntington's disease: selective increase in the density of calretinin-immunoreactive medium-sized neurons

scientific article published in November 1996

Striatal interneurons in Huntington's disease: selective increase in the density of calretinin-immunoreactive medium-sized neurons is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/MDS.870110605
P698PubMed publication ID8914086

P50authorAndré ParentQ2848396
P2093author name stringCicchetti F
P2860cites workUse of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) proceduresQ26778382
Alternative excitotoxic hypothesesQ35227246
Sparing of striatal neurons coexpressing calretinin and substance P (NK1) receptor in Huntington's diseaseQ45293223
The diagnosis of Huntington's diseaseQ45297907
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectHuntington's diseaseQ190564
striatumQ1319792
P304page(s)619-626
P577publication date1996-11-01
P1433published inMovement DisordersQ1486418
P1476titleStriatal interneurons in Huntington's disease: selective increase in the density of calretinin-immunoreactive medium-sized neurons
P478volume11

Reverse relations

cites work (P2860)
Q34216909'New' functions for 'old' proteins: the role of the calcium-binding proteins calbindin D-28k, calretinin and parvalbumin, in cerebellar physiology. Studies with knockout mice
Q51811057Age-related changes in striatal nitric oxide synthase-immunoreactive interneurones in the dystonic dtsz mutant hamster.
Q35907258All-trans-retinoid acid induces the differentiation of encapsulated mouse embryonic stem cells into GABAergic neurons
Q36606399Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies
Q35092246Apoptosis in Huntington's disease.
Q48496424Calretinin gene expression in the human thalamus
Q42190041Changes in striatal activity and functional connectivity in a mouse model of Huntington's disease
Q73209561Chemical anatomy of striatal interneurons in normal individuals and in patients with Huntington's disease
Q48147783Differential expression of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor subunits by calretinin-immunoreactive neurons in the human striatum
Q36012795Differential localization of the GluR1 and GluR2 subunits of the AMPA-type glutamate receptor among striatal neuron types in rats
Q52690256Disrupted striatal neuron inputs and outputs in Huntington's disease.
Q37338808Expression of genes encoding the calcium signalosome in cellular and transgenic models of Huntington's disease.
Q27023050Genetics and neuropathology of Huntington's disease
Q28587499Neuronal degeneration in the basal ganglia and loss of pallido-subthalamic synapses in mice with targeted disruption of the Huntington's disease gene
Q42441048Parvalbumin-immunoreactive neurons in the human claustrum
Q28394979Review: Modulation of striatal neuron activity by cyclic nucleotide signaling and phosphodiesterase inhibition
Q38616832Selective Sparing of Striatal Interneurons after Poly (ADP-Ribose) Polymerase 1 Inhibition in the R6/2 Mouse Model of Huntington's Disease
Q34017941Somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of Huntington's disease transgenic mice
Q73693635Striatal interneurons expressing calretinin, parvalbumin or NADPH-diaphorase: a comparative study in the rat, monkey and human
Q89599712Thalamostriatal degeneration contributes to dystonia and cholinergic interneuron dysfunction in a mouse model of Huntington's disease
Q38663086The Complexity of Clinical Huntington's Disease: Developments in Molecular Genetics, Neuropathology and Neuroimaging Biomarkers
Q36045254The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration
Q33939097The selective vulnerability of striatopallidal neurons
Q39123728The calretinin interneurons of the striatum: comparisons between rodents and primates under normal and pathological conditions.

Search more.